Mohan E Tulapurkar, Kari Ann Shirey, Katerina N Lugkey, Wendy Luo, Ritu Lal, Adam Galan, Omar Mahmoud, Nathaniel McClean, Kiruphagaran Thangaraju, Daniel Cericola, Daniel Lewis, William A Murphy, Steven Fletcher, Alexander D MacKerell, Stefanie N Vogel, Paul Shapiro, Jeffrey D Hasday
We previously identified a small molecule, UM101, predicted to bind to the substrate-binding groove of p38aMitogen-activated Protein Kinase (MAPK) near the binding site of its proinflammatory substrate, MAPK-activated protein kinase (MK2). UM101 exhibited anti-inflammatory, endothelial-stabilizing, and lung-protective effects. To overcome its limited aqueous solubility and p38a binding affinity, we designed an analog of UM101, GEn-1124, with improved aqueous solubility, stability, and p38a binding affinity...
September 16, 2024: Journal of Pharmacology and Experimental Therapeutics